Thus, considering the possibility that CRP and endotoxin are both risk factors for atherosclerosis and may act synergistically in vitro[20] and in vivo, our strategy was not to remove the endotoxin present in CRP but to measure the concentrations present. The gene discussed is CRP; the disease is atherosclerosis.